Verovaccines is a biopharmaceutical company developing combination vaccines for animal health using a new proprietary technology. These vaccines offer several solutions for medical and industry needs in animal health: new vaccines to reduce antibiotic use, simple vaccine combinations and heat-stable vaccines for widespread use in emerging and developing countries. The technology can be used for many pathogens and is highly scalable. The company has built a portfolio of six vaccine programs, three of which achieved proof of concept in the target animal.

Press releases

3. December 2019

Vaccine developer Verovaccines GmbH concludes international pharma cooperation agreement

Verovaccines enters into first collaboration with an international pharmaceutical company to jointly develop a veterinary vaccine The company was financed for the seed phase by High-Tech Gründerfonds, Business Angels and the founders as well as a seven-figure GO-Bio grant The goal is to develop and commercialize novel, cost-effective vaccines with high safety and efficacy for animal health The biotech start-up Verovaccines GmbH has signed the first cooperation agreement with a Japanese

Info & Contact

+49 (345) 131428-90


Verovaccines GmbH
Blücherstraße 26
06120 Halle/Saale

In portfolio

29. Dec 2017

Kay G. Balster

Principal / Authorized signatory